Literature DB >> 7599833

Cartilaginous airway dimensions and airflow obstruction in human lungs.

H A Tiddens1, P D Paré, J C Hogg, W C Hop, R Lambert, J C de Jongste.   

Abstract

Airway wall remodeling in asthma and chronic obstructive pulmonary disease (COPD) can have a profound effect on the function of the airways. We tested the hypothesis that airflow obstruction and estimates of peripheral airway inflammation correlate with airway wall thickness and the amount of bronchial smooth muscle in cartilaginous airways. In addition, we estimated the theoretical relation between airway dimensions and airway resistance with a computational model. Lung tissue was obtained from 72 patients with different degrees of COPD who were operated on for a solitary peripheral lung lesion. In 341 transversely cut cartilaginous airway sections we measured airway size and airway wall dimensions. Inflammatory changes from the same lungs were scored in noncartilaginous airways. Preoperatively measured maximum expiratory flows and the response to a bronchodilator were correlated with airway wall dimensions. Maximum expiratory flow, the reversibility of airflow obstruction, and peripheral airway inflammation were significantly related to the airway wall area but not to the smooth muscle area. We conclude that airflow obstruction and its reversibility in COPD is in part caused by thickening of the cartilaginous airway wall and is related to inflammatory changes.

Entities:  

Mesh:

Year:  1995        PMID: 7599833     DOI: 10.1164/ajrccm.152.1.7599833

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Airway wall attenuation: a biomarker of airway disease in subjects with COPD.

Authors:  George R Washko; Mark T Dransfield; Raúl San José Estépar; Alejandro Diaz; Shin Matsuoka; Tsuneo Yamashiro; Hiroto Hatabu; Edwin K Silverman; William C Bailey; John J Reilly
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

2.  Bronchial morphometry in smokers: comparison with healthy subjects by using 3D CT.

Authors:  Michel Montaudon; Patrick Berger; Mathieu Lederlin; Roger Marthan; José Manuel Tunon-de-Lara; François Laurent
Journal:  Eur Radiol       Date:  2009-01-24       Impact factor: 5.315

3.  Regional airflow obstruction after bronchoconstriction and subsequent bronchodilation in subjects without pulmonary disease.

Authors:  E T Geier; R J Theilmann; G K Prisk; R C Sá
Journal:  J Appl Physiol (1985)       Date:  2019-05-23

Review 4.  The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  James C Hogg; Peter D Paré; Tillie-Louise Hackett
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

5.  The Case of Missing Airways in Chronic Obstructive Pulmonary Disease.

Authors:  Alejandro A Díaz
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

6.  Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).

Authors:  Benjamin M Smith; Eric A Hoffman; Dan Rabinowitz; Eugene Bleecker; Stephanie Christenson; David Couper; Kathleen M Donohue; Meilan K Han; Nadia N Hansel; Richard E Kanner; Eric Kleerup; Stephen Rennard; R Graham Barr
Journal:  Thorax       Date:  2014-06-13       Impact factor: 9.139

7.  Computed tomographic measures of airway morphology in smokers and never-smoking normals.

Authors:  G R Washko; A A Diaz; V Kim; R G Barr; M T Dransfield; J Schroeder; J J Reilly; J W Ramsdell; A McKenzie; E J R Van Beek; D A Lynch; J P Butler; M K Han
Journal:  J Appl Physiol (1985)       Date:  2014-01-16

Review 8.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease.

Authors:  Harvey O Coxson
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

10.  Altered fibroblast proteoglycan production in COPD.

Authors:  Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif T Eriksson; Jonas S Erjefält; Claes-Göran Löfdahl; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2010-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.